1. Market Research
  2. > Pharmaceutical Market Trends
  3. > India Active Pharmaceutical Ingredients (API) Industry 2015 Market Research Report

Summary


The India Active Pharmaceutical Ingredients (API) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Active Pharmaceutical Ingredients (API) industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Active Pharmaceutical Ingredients (API) market analysis is provided for the India markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on India major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Active Pharmaceutical Ingredients (API) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 323 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

India Active Pharmaceutical Ingredients (API) Industry 2015 Market Research Report
Table of Contents

Chapter One Industry Overview
1.1 Definition and Specifications of Active Pharmaceutical Ingredients (API)
1.2 Classification of Active Pharmaceutical Ingredients (API)
1.3 Applications of Active Pharmaceutical Ingredients (API)
1.4 Industry Chain Structure of Active Pharmaceutical Ingredients (API)
1.5 Industry Overview of Active Pharmaceutical Ingredients (API)
1.6 Industry Policy Analysis of Active Pharmaceutical Ingredients (API)
1.7 Industry News Analysis of Active Pharmaceutical Ingredients (API)

Chapter Two Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API)
2.1 Bill of Materials (BOM) of Active Pharmaceutical Ingredients (API)
2.2 BOM Price Analysis of Active Pharmaceutical Ingredients (API)
2.3 Labor Cost Analysis of Active Pharmaceutical Ingredients (API)
2.4 Depreciation Cost Analysis of Active Pharmaceutical Ingredients (API)
2.5 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API)
2.6 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)

Chapter Three Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of India Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of India Key Active Pharmaceutical Ingredients (API) Manufacturers in 2014
3.3 RandD Status and Technology Source of India Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of India Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014

Chapter Four Production Analysis of Active Pharmaceutical Ingredients (API) by Regions, Technology, and Applications
4.1 India Production of Active Pharmaceutical Ingredients (API) by Regions (Key Provinces) 2010-2015
4.2 India Production of Active Pharmaceutical Ingredients (API) by Product Types 2010-2015
4.3 India Sales of Active Pharmaceutical Ingredients (API) by Applications 2010-2015
4.4 Price Analysis of India Active Pharmaceutical Ingredients (API) Key Manufacturers in 2015
4.5 India Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Active Pharmaceutical Ingredients (API) 2010-2015

Chapter Five Sales and Revenue Analysis of Active Pharmaceutical Ingredients (API) by Regions
5.1 India Sales of Active Pharmaceutical Ingredients (API) by Regions 2010-2015
5.2 India Revenue of Active Pharmaceutical Ingredients (API) by Regions 2010-2015
5.3 India Price Analysis of Active Pharmaceutical Ingredients (API) Sales by Regions 2010-2015
5.4 India Price, Cost and Gross of Active Pharmaceutical Ingredients (API) 2010-2015

Chapter Six Analysis of Active Pharmaceutical Ingredients (API) Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity Production Sales Revenue of Active Pharmaceutical Ingredients (API) 2010-2015
6.2 Production Sales Market Share Analysis of Active Pharmaceutical Ingredients (API) 2014-2015
6.3 Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2010-2015
6.4 Supply, Consumption and Shortage of Active Pharmaceutical Ingredients (API) 2010-2015
6.5 Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Active Pharmaceutical Ingredients (API) 2010-2015

Chapter Seven Analysis of Active Pharmaceutical Ingredients (API) Industry Key Manufacturers
7.1 Cipla
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Cipla SWOT Analysis

7.2 Aurobindo Pharma
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Aurobindo Pharma SWOT Analysis

7.3 Dr. Reddy's Laboratories
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Dr. Reddy's Laboratories SWOT Analysis

7.4 Anuh Pharma
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Anuh Pharma SWOT Analysis

7.5 Alembic Pharmaceuticals
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Alembic Pharmaceuticals SWOT Analysis

7.6 A. R. Life Sciences
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 A. R. Life Sciences SWOT Analysis

7.7 Atul Bioscience
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Atul Bioscience SWOT Analysis

7.8 Biocon
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Biocon SWOT Analysis

7.9 Cadila Pharmaceuticals
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Cadila Pharmaceuticals SWOT Analysis

7.10 Calyx Chemicals and Pharmaceuticals
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Calyx Chemicals and Pharmaceuticals SWOT Analysis

7.11 CIRON Drugs and Pharmaceuticals
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 CIRON Drugs and Pharmaceuticals SWOT Analysis

7.12 CTX Life Sciences
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 CTX Life Sciences SWOT Analysis

7.13 Dishman Pharmaceuticals and Chemicals
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Dishman Pharmaceuticals and Chemicals SWOT Analysis

7.14 Elder Pharmaceuticals
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Elder Pharmaceuticals SWOT Analysis

7.15 Emcure Pharmaceuticals
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Emcure Pharmaceuticals SWOT Analysis

7.16 FDC
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 FDC SWOT Analysis

7.17 Glenmark Pharmaceuticals
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Glenmark Pharmaceuticals SWOT Analysis

7.18 Hetero Drugs
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Hetero Drugs SWOT Analysis

7.19 Hikal
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 Hikal SWOT Analysis

7.20 Ind-Swift Laboratories
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Ind-Swift Laboratories SWOT Analysis

7.21 Ipca Laboratories
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 Ipca Laboratories SWOT Analysis

7.22 J. B. Chemicals and Pharmaceuticals
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 J. B. Chemicals and Pharmaceuticals SWOT Analysis

7.23 Laurus Labs
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Laurus Labs SWOT Analysis

7.24 Lupin
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.24.4 Lupin SWOT Analysis

7.25 Mangalam Drugs and Organics
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.25.4 Mangalam Drugs and Organics SWOT Analysis

7.26 Mylan Laboratories
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.26.4 Mylan Laboratories SWOT Analysis

7.27 Orchid Chemicals and Pharmaceuticals
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.27.4 Orchid Chemicals and Pharmaceuticals SWOT Analysis

7.28 Ranbaxy Laboratories
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.28.4 Ranbaxy Laboratories SWOT Analysis

7.29 Sandoz
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.29.4 Sandoz SWOT Analysis

7.30 Sequent Scientific
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.30.4 Sequent Scientific SWOT Analysis

7.31 Shasun Pharmaceuticals
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.31.4 Shasun Pharmaceuticals SWOT Analysis

7.32 Sterling Biotech
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.32.4 Sterling Biotech SWOT Analysis

7.33 Sun Pharmaceutical Industries
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.33.4 Sun Pharmaceutical Industries SWOT Analysis

7.34 The Piramal Group
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.34.4 The Piramal Group SWOT Analysis

7.35 Torrent Pharmaceuticals
7.35.1 Company Profile
7.35.2 Product Picture and Specification
7.35.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.35.4 Torrent Pharmaceuticals SWOT Analysis

7.36 Unichem Laboratories
7.36.1 Company Profile
7.36.2 Product Picture and Specification
7.36.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.36.4 Unichem Laboratories SWOT Analysis

7.37 Wockhardt
7.37.1 Company Profile
7.37.2 Product Picture and Specification
7.37.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.37.4 Wockhardt SWOT Analysis

Chapter Eight Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Active Pharmaceutical Ingredients (API) Product Types
8.5 Market Share Analysis of Different Active Pharmaceutical Ingredients (API) Price Levels
8.6 Gross Margin Analysis of Different Active Pharmaceutical Ingredients (API) Applications

Chapter Nine Marketing Trader or Distributor Analysis of Active Pharmaceutical Ingredients (API)
9.1 Marketing Channels Status of Active Pharmaceutical Ingredients (API)
9.2 Traders or Distributors of Active Pharmaceutical Ingredients (API) with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Active Pharmaceutical Ingredients (API)
9.4 India Import, Export and Trade Analysis of Active Pharmaceutical Ingredients (API)

Chapter Ten Development Trend of Active Pharmaceutical Ingredients (API) Industry 2015-2020
10.1 Capacity and Production Overview of Active Pharmaceutical Ingredients (API) 2015-2020
10.2 Production Market Share by Product Types of Active Pharmaceutical Ingredients (API) 2015-2020
10.3 Sales and Sales Revenue Overview of Active Pharmaceutical Ingredients (API) 2015-2020
10.4 India Sales of Active Pharmaceutical Ingredients (API) by Applications 2015-2020
10.5 Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Active Pharmaceutical Ingredients (API) 2015-2020

Chapter Eleven Industry Chain Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
11.1 Major Raw Materials Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
11.2 Manufacturing Equipment Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
11.3 Major Players of Active Pharmaceutical Ingredients (API) with Contact Information
11.4 Key Consumers of Active Pharmaceutical Ingredients (API) with Contact Information
11.5 Supply Chain Relationship Analysis of Active Pharmaceutical Ingredients (API)

Chapter Twelve New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredients (API)
12.1 New Project SWOT Analysis of Active Pharmaceutical Ingredients (API)
12.2 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredients (API)

Chapter Thirteen Conclusion of the India Active Pharmaceutical Ingredients (API) Industry 2015 Market Research Report


List of Tables and Figures

Figure Picture of Active Pharmaceutical Ingredients (API)
Table Product Specifications of Active Pharmaceutical Ingredients (API)
Table Classification of Active Pharmaceutical Ingredients (API)
Figure India Sales Market Share of Active Pharmaceutical Ingredients (API) by Product Types in 2014
Table Applications of Active Pharmaceutical Ingredients (API)
Figure India Sales Market Share of Active Pharmaceutical Ingredients (API) by Applications in 2014
Figure Industry Chain Structure of Active Pharmaceutical Ingredients (API)
Table India Industry Overview of Active Pharmaceutical Ingredients (API)
Table Industry Policy of Active Pharmaceutical Ingredients (API)
Table Industry News List of Active Pharmaceutical Ingredients (API)
Table Bill of Materials (BOM) of Active Pharmaceutical Ingredients (API)
Table Bill of Materials (BOM) Price of Active Pharmaceutical Ingredients (API)
Table Labor Cost of Active Pharmaceutical Ingredients (API)
Table Depreciation Cost of Active Pharmaceutical Ingredients (API)
Table Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API) in 2014
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
Table Capacity (K Units) and Commercial Production Date of India Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014
Table Manufacturing Plants Distribution of India Key Active Pharmaceutical Ingredients (API) Manufacturers in 2014
Table RandD Status and Technology Source of India Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014
Table Raw Materials Sources Analysis of India and India Active Pharmaceutical Ingredients (API) Key Manufacturers in 2014
Table India Production of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (K Units)
Table India Production Market Share of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (%)
Figure India Production Market Share of Active Pharmaceutical Ingredients (API) by Regions in 2014
Figure India Production Market Share of Active Pharmaceutical Ingredients (API) by Regions in 2015
Table India Production of Active Pharmaceutical Ingredients (API) by Product Types in 2010-2015 (K Units)
Table India Production Market Share of Active Pharmaceutical Ingredients (API) by Product Types in 2010-2015 (%)
Figure India Production Market Share of Active Pharmaceutical Ingredients (API) by Technology in 2014
Figure India Production Market Share of Active Pharmaceutical Ingredients (API) by Technology in 2015
Figure India Sales of Active Pharmaceutical Ingredients (API) by Applications 2010-2015 (K Units)
Table India Production Market Share of Active Pharmaceutical Ingredients (API) by Applications 2010-2015 (%)
Figure India Production Market Share of Active Pharmaceutical Ingredients (API) by Applications in 2014
Figure India Production Market Share of Active Pharmaceutical Ingredients (API) by Applications in 2015
Table Price Comparison of India Active Pharmaceutical Ingredients (API) Key Manufacturers in 2015 (USD/Unit)
Table India Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Active Pharmaceutical Ingredients (API) 2010-2015
Table India Sales of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (K Units)
Table India Sales Market Share of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (%)
Figure India Sales of Active Pharmaceutical Ingredients (API) by Regions in 2014 (K Units)
Figure India Sales of Active Pharmaceutical Ingredients (API) by Regions in 2015 (K Units)
Table India Revenue of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (M USD)
Table India Revenue of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (%)
Figure India Revenue of Active Pharmaceutical Ingredients (API) by Regions in 2014 (%)
Figure India Revenue of Active Pharmaceutical Ingredients (API) by Regions in 2015 (%)
Table Sales Price of Active Pharmaceutical Ingredients (API) by Regions 2010-2015 (USD/Unit)
Table India Price Analysis of Active Pharmaceutical Ingredients (API) 2010-2015 (USD/Unit)
Table India Cost Analysis of Active Pharmaceutical Ingredients (API) 2010-2015 (USD/Unit)
Table India Gross Analysis of Active Pharmaceutical Ingredients (API) 2010-2015
Table India and Major Manufacturers Capacity of Active Pharmaceutical Ingredients (API) 2010-2015 (K Units)
Table India Capacity Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers 2010-2015 (%)
Table India and Major Manufacturers Production of Active Pharmaceutical Ingredients (API) 2010-2015 (K Units)
Table India Production Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers 2010-2015 (%)
Table India and Major Manufacturers Sales of Active Pharmaceutical Ingredients (API) 2010-2015 (K Units)
Table India Sales Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers 2010-2015 (%)
Table India and Major Manufacturers Sales Revenue of Active Pharmaceutical Ingredients (API) 2010-2015 (M USD)
Table India Sales Revenue Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers 2010-2015 (%)
Figure India Capacity (K Units), Production (K Units) and Growth Rate of Active Pharmaceutical Ingredients (API) 2010-2015
Figure India Capacity Utilization Rate of Active Pharmaceutical Ingredients (API) 2010-2015
Figure India Sales Revenue (M USD) and Growth Rate of Active Pharmaceutical Ingredients (API) 2010-2015
Figure India Production Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers in 2014
Figure India Production Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers in 2015
Figure India Sales Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers in 2014
Figure India Sales Market Share of Major Active Pharmaceutical Ingredients (API) Manufacturers in 2015
Table India Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2010-2015 (K Units)
Table India and Major Manufacturers Local Sales Export Import of Active Pharmaceutical Ingredients (API) 2010-2015 (K Units)
Table India Supply, Consumption and Shortage of Active Pharmaceutical Ingredients (API) 2010-2015 (K Units)
Table India Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2010-2015 (K Units)
Table Price of India Active Pharmaceutical Ingredients (API) Major Manufacturers 2010-2015 (USD/Unit)
Table Gross Margin of India Active Pharmaceutical Ingredients (API) Major Manufacturers 2010-2015
Table India and Major Manufacturers Revenue of Active Pharmaceutical Ingredients (API) 2010-2015 (M USD)
Table India Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Active Pharmaceutical Ingredients (API) 2010-2015
Table Cipla Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Cipla
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cipla 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Cipla 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Cipla 2010-2015
Table Cipla Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Aurobindo Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Aurobindo Pharma
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aurobindo Pharma 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Aurobindo Pharma 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Aurobindo Pharma 2010-2015
Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Dr. Reddy's Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Dr. Reddy's Laboratories
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Dr. Reddy's Laboratories 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Dr. Reddy's Laboratories 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Dr. Reddy's Laboratories 2010-2015
Table Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Anuh Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Anuh Pharma
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Anuh Pharma 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Anuh Pharma 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Anuh Pharma 2010-2015
Table Anuh Pharma Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Alembic Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Alembic Pharmaceuticals
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alembic Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Alembic Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Alembic Pharmaceuticals 2010-2015
Table Alembic Pharmaceuticals Active Pharmaceutical Ingredients (API) SWOT Analysis
Table A. R. Life Sciences Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of A. R. Life Sciences
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of A. R. Life Sciences 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of A. R. Life Sciences 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of A. R. Life Sciences 2010-2015
Table A. R. Life Sciences Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Atul Bioscience Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Atul Bioscience
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Atul Bioscience 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Atul Bioscience 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Atul Bioscience 2010-2015
Table Atul Bioscience Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Biocon
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biocon 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Biocon 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Biocon 2010-2015
Table Biocon Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Cadila Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Cadila Pharmaceuticals
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cadila Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Cadila Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Cadila Pharmaceuticals 2010-2015
Table Cadila Pharmaceuticals Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Calyx Chemicals and Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Calyx Chemicals and Pharmaceuticals
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Calyx Chemicals and Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Calyx Chemicals and Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Calyx Chemicals and Pharmaceuticals 2010-2015
Table Calyx Chemicals and Pharmaceuticals Active Pharmaceutical Ingredients (API) SWOT Analysis
Table CIRON Drugs and Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of CIRON Drugs and Pharmaceuticals
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CIRON Drugs and Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of CIRON Drugs and Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of CIRON Drugs and Pharmaceuticals 2010-2015
Table CIRON Drugs and Pharmaceuticals Active Pharmaceutical Ingredients (API) SWOT Analysis
Table CTX Life Sciences Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of CTX Life Sciences
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CTX Life Sciences 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of CTX Life Sciences 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of CTX Life Sciences 2010-2015
Table CTX Life Sciences Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Dishman Pharmaceuticals and Chemicals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Dishman Pharmaceuticals and Chemicals
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Dishman Pharmaceuticals and Chemicals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Dishman Pharmaceuticals and Chemicals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Dishman Pharmaceuticals and Chemicals 2010-2015
Table Dishman Pharmaceuticals and Chemicals Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Elder Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Elder Pharmaceuticals
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Elder Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Elder Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Elder Pharmaceuticals 2010-2015
Table Elder Pharmaceuticals Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Emcure Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Emcure Pharmaceuticals
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Emcure Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Emcure Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Emcure Pharmaceuticals 2010-2015
Table Emcure Pharmaceuticals Active Pharmaceutical Ingredients (API) SWOT Analysis
Table FDC Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of FDC
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of FDC 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of FDC 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of FDC 2010-2015
Table FDC Active Pharmaceutical Ingredients (API) SWOT Analysis
Table Glenmark Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Active Pharmaceutical Ingredients (API) Picture and Specifications of Glenmark Pharmaceuticals
Table Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Glenmark Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Capacity (K Units), Production (K Units) and Growth Rate of Glenmark Pharmaceuticals 2010-2015
Figure Active Pharmaceutical Ingredients (API) Production (K Units) and India Market Share of Glenmark Pharmaceuticals 2010-2015
Table Glenmark Pharmace

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.